Search result for 'roche pharma'

FDI inflows into India are expected to grow strongly in 2026. Learn about the key drivers, investment announcements, and policy changes.

Roche Pharma commits 1.5 billion Swiss Franc investment in India over five years, focusing on R&D and expanding patient access.

Roche Pharma commits 1.5 billion Swiss Franc investment in India over five years, focusing on R&D and expanding patient access.

Roche Pharma partners with 10 government hospitals in India to strengthen clinical trial capabilities. Training provided to 400+ professionals.

Roche Pharma India appoints Rajwinder Mehdwan as Country General Manager, effective April 1, 2025. Mehdwan brings over 20 years of experience in the healthcare industry.

Roche Pharma India launches Vabysmo (faricimab) for age-related macular degeneration and diabetic macular edema, the two leading causes of vision loss.

Roche Pharma India introduces Ocrevus (Ocrelizumab), a groundbreaking treatment for Multiple Sclerosis (MS), offering a twice-yearly dosing option for both RRMS and PPMS.